PolarityTE, Inc.

    Jurisdiction
    United States
    LEI
    549300S23HGL0P1Y1N41
    ISIN
    US7310942070 (PTE)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €62.89K
    Gross margin
    -14,053.4%
    EBIT
    -€15.77M
    EBIT margin
    -25,071.2%
    Net income
    €15.00M
    Net margin
    23,845.2%

    Statement period: - (published )

    Dividends

    Last dividend amount
    $0.34
    Ex date

    Earnings Calls

    Latest earnings call: August 11, 2022

    Add to watchlist

    Notifications